| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enliven Therapeutics, Inc. (ELVN) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. ELVN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 890.4K | $40.92M | - | |
| CEO | 875.0K | $40.22M | - | |
| Other | 740.2K | $34.02M | - | |
| 10% | 245.7K | $11.29M | -281,408 | |
| COO | 215.0K | $9.88M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 22, 2023 | Heyman Richard A.74 | Director | Sell | 216 | $13.00 | $2,808.00 | - | +21.6% | +51.3% | |
| Dec 22, 2023 | Lyssikatos Joseph P50 | Chief Scientific Officer | Sale+OE | 6,566 | $13.07 | $85,790.04 | -100% | +21.6% | +51.3% | |
| Dec 20, 2023 | Kintz Samuel51 | President And CEO | Sale+OE | 7,779 | $13.01 | $101,238.24 | -100% | +43.9% | +87.6% | |
| Dec 20, 2023 | Lyssikatos Joseph P50 | Chief Scientific Officer | Sale+OE | 8,888 | $13.01 | $115,645.65 | -100% | +43.9% | +87.6% | |
| Dec 20, 2023 | Heyman Richard A.74 | Director | Sell | 4,280 | $13.02 | $55,727.05 | -1.3% | +43.9% | +87.6% | |
| Nov 3, 2023 | Lyssikatos Joseph P50 | Chief Scientific Officer | Sale+OE | 8,546 | $13.08 | $111,750.91 | -100% | +26.5% | +112.5% | |
| Nov 3, 2023 | Kintz Samuel51 | President And CEO | Sale+OE | 8,026 | $13.08 | $104,999.34 | -100% | +26.5% | +112.5% | |
| Sep 29, 2023 | Lyssikatos Joseph P50 | Chief Scientific Officer | Sale+OE | 12,000 | $13.62 | $163,497.60 | -100% | +6.7% | +76.6% | |
| Sep 26, 2023 | 5am Partners Vi, LLC | 10% Owner | Sell | 197,500 | $15.00 | $2,962,500.00 | -3.7% | +1.5% | +69.8% | |
| Sep 25, 2023 | Kintz Samuel51 | President And CEO | Sale+OE | 12,000 | $13.81 | $165,691.20 | -100% | +4.3% | +73.3% |